Search database
Filter
101
Text search: thrombocytopenia after vaccination
Featured
Language
Document type
37
34
12
8
4
4
1
1
Countries / Regions
11
5
4
4
4
3
2
2
2
2
2
1
1
1
1
1
1
1
1
Authors & Publishers
23
5
5
4
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
40
16
3
3
2
Toolboxes
36
7
4
3
3
3
2
2
2
2
1
1
1
1
1
13 July 2021 The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater for this specific group of population using both pass ... more

Philippines: HIV Immunization Guidelines

Rontgene M. Solante, Manolito L. Chua Philippine Society for Microbiology and Infectious Diseases (2010) C1
updated version: 04/10/2021 Information about vaccine administration
These are standing orders for eligible nurses and healthcare professionals to administer the Moderna COVID-19 vaccine to persons 18 years of age and older
10 May 2021. Manufactureres: SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])] Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)] The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto ... more
July 2021
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn ... more
J Hepatol (2017), http://dx.doi.org/10.1016/j.jhep.2017.03.021
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
7 April 2021
29 September 2021
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
6 June 2022 These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. Th ... more
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572